PMS5 Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil
Autor: | Buschinelli, C.T., Maximo, M.F.M., Tsuchiya, C.T., Tobaruella, F.S., Gonçalves, T.M. |
---|---|
Jazyk: | angličtina |
Zdroj: | Value in Health. (7):A716 |
ISSN: | 1098-3015 |
DOI: | 10.1016/j.jval.2013.08.2217 |
Databáze: | OpenAIRE |
Externí odkaz: |